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Obesity, Sleep Apnea, LV Remodeling and Myocardial Fibrosis Assessed with Cardiac MRI
Background: Both obesity and sleep apnea (SA) are predictive of heart failure (HF). Limited data are available regarding the independent effects 
of SA and obesity on left ventricular (LV) remodeling.
Methods: We recruited 280 subjects (267 males) undergoing cardiac MRI. Clinical variables were ascertained by chart review. We assessed 
the relationship between the diagnosis of SA, obesity, and the following parameters: (1) LV mass, using steady-state free precession imaging; (2) 
LV geometry, expressed as LV mass / volume; (3) In a subsample (n=48), we assessed diffuse myocardial fibrosis, quantified as the extracellular 
volume fraction (ECV) from pre/post-gadolinium myocardial T1 measurements (Look-Locker sequences), as follows: ECV= λ * (1-hematocrit). 
Lambda (λ ), the Gd partition coefficient between blood and myocardium, was computed as the slope of the linear relationship between myocardial 
R1 versus blood R1 before and after Gd administration.
results: Of the 280 subjects, 62 (22%) subjects were diagnosed with SA and 125 (45%) were obese. In SA patients, 76% were obese. In regression 
models that adjusted for central mean pressure, hypertension, diabetes (DM), smoking status, and antihypertensive drugs, body mass index (BMI, 
standardized β=0.20; P=0.002), but not SA (P=0.18), was positively associated with increased LV mass. However, SA was independently associated 
with eccentric geometry (β for LV mass/cavity volume ratio=-0.17; P=0.006), whereas BMI was associated with concentric remodeling (β=0.20; 
P=0.002). While somewhat attenuated, these relationships persisted after excluding individuals with HF or significant valvular disease. Myocardial 
fibrosis was associated with DM (β=0.56; P=0.001) but neither obesity nor SA (P>0.05).
conclusions: Clinical SA and obesity may be differentially associated with pre-clinical phenotypes of LV remodeling. SA was independently 
associated with eccentric LV remodeling but not LV hypertrophy; whereas, higher BMI was associated with increased LV mass and concentric LV 
hypertrophy. Further prospective studies will be needed to validate these findings.
